Al Meezan - Qatary Legal Portal | Legislations | Resolution No. 20 of 2000 by the Minister of Public Health on the Formation of the Standing Committee of the Registration of Pharmaceutical Companies and of their Products, Functions and Modus Operandi | Articles

23 April 2021

12 ‏Ramadhaan 1442

Legislations of Qatar 5686 legislations - 58361 Articles
Legislations of Qatar - International Agreements
Legislations of Qatar- Rulings

Resolution No. 20 of 2000 by the Minister of Public Health on the Formation of the Standing Committee of the Registration of Pharmaceutical Companies and of their Products, Functions and Modus Operandi

Law Summary Record Type: Ministerial DecreeNumber: 20Date: 31/12/2000 Corresponding to 05/10/1421 HijriNumber of Articles: 12Status: In force

Official Gazette :Issue: 1Offcial Journal Issue Publication Date: 10/02/2001 Corresponding to 17/11/1421 HijriPage from: 433

Add New Section

Section Name

Article 2
Starting Date: 31/12/2000

The Committee shall assume the registration of the pharmaceutical companies and their products and exercise all the powers set forth in Law No. 1 of 1986 referred to above, in particular the following:

Receiving applications for the registration of pharmaceutical companies and their products, registering these applications in the book allocated therefor, and furnishing the applicant with a receipt reflecting the number and date of registration.
Examining the registration of applications and refusing such registration where justified.
Conducting a search of pharmaceutical companies that change or add to their drug products, and approving or rejecting their registration.
Recording pharmaceutical companies approved by the Committee in the pharmaceutical companies record under a specific serial number, recording this number on the external and internal medicine cards, and furnishing the applicant with a certificate thereof.
Recording the names of medicines approved by the Committee in the record under a specific serial number, recording this number on the external and internal medicine cards, and furnishing the applicant with a certificate thereof.
Receiving notifications from pharmaceutical companies and establishments of their types and quantities of medications, any changes in possession thereof, and any data requested by the Committee.
Preparing forms and records necessary for registration.
Publishing the names of pharmaceutical companies and products that have been recorded regularly in the Official Gazette, as well as all amendments or additions thereto approved by the Committee.
Considering possible violations by pharmaceutical companies and establishments of the provisions of Law No. 1of 1986, referred to above; taking the necessary measures to cancel their registration where such violations are proved; and cancelling the registration of any medication that violates the prescribed specifications.
Issuing periodic bulletins on pharmaceutical companies, establishments and products.